TEVA PHARMACEUTICAL INDUSTRIES LIMITED Noncontrolling Interest, Increase from Subsidiary Equity Issuance
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $165.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-03-31 was $165.00M, a 157.81% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for fiscal 2025 was $165.00M, a 157.81% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, increase from subsidiary equity issuance for fiscal 2024 was $64.00M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 6 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-07-29 | $165.00M 10-K · filed 2026-02-03 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-07-29 | $165.00M 10-Q · filed 2025-11-05 | $165.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $165.00M 10-Q · filed 2026-07-29 | $165.00M derived: sum of 3 quarters · filed 2026-07-29 | $165.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $165.00M 10-Q · filed 2026-04-29 | $165.00M derived: sum of 2 quarters · filed 2026-04-29 | $165.00M derived: sum of 3 quarters · filed 2026-04-29 | $165.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $0.00 derived: sum of 2 quarters · filed 2025-02-05 | $0.00 derived: sum of 3 quarters · filed 2025-02-05 | $64.00M 10-K · filed 2025-02-05 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $64.00M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $64.00M 10-Q · filed 2024-07-31 | ||
| 2024-03-31 | $64.00M 10-Q · filed 2024-05-08 |